Identification of lactate dehydrogenase A inhibitors using fragment-based lead generation

被引:0
|
作者
Ward, Richard A.
Winter, Jon
De Savi, Chris
Greenwood, Ryan
Pearson, Stuart
Hooper, Alice
Tam, Kin
Hunter, Alison
Lane, Clare
Tucker, Julie
Brassington, Clare
Caputo, Alessandro
Vogtherr, Martin
Watson, Martin
Holdgate, Geoff
Davies, Gareth
Tart, Jonathan
Wingfield, Jonathan
Goodwin, Louise
Whalley, Nicky
Critchlow, Susan
Hudson, Kevin
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
230-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Structure-guided drug discovery for protein kinases using fragment-based lead identification/lead optimization
    Burley, SK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2763 - U2764
  • [32] EXPERIENCES IN FRAGMENT-BASED LEAD DISCOVERY
    Hubbard, Roderick E.
    Murray, James B.
    FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 : 509 - 531
  • [33] Structure-guided Drug Discovery for Protein Kinases Using Fragment-based Lead Identification/Lead Optimization
    Burley, Stephen K.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C108 - C109
  • [34] Fragment-Based Dynamic Combinatorial Chemistry for Identification of Selective α-Glucosidase Inhibitors
    Wu, Yao
    Liu, Changming
    Hu, Lei
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (11): : 1791 - 1796
  • [35] Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors
    Ng, Pearly Shuyi
    Foo, Klement
    Sim, Sandra
    Wang, Gang
    Huang, Chuhui
    Tan, Li Hong
    Poulsen, Anders
    Liu, Boping
    Tee, Doris Hui Ying
    Ahmad, Nur Huda Binte
    Wang, Sifang
    Ke, Zhiyuan
    Lee, May Ann
    Kwek, Zekui P.
    Joy, Joma
    Anantharajan, Jothi
    Baburajendran, Nithya
    Pendharkar, Vishal
    Manoharan, Vithya
    Vuddagiri, Susmitha
    Sangthongpitag, Kanda
    Hill, Jeffrey
    Keller, Thomas H.
    Hung, Alvin W.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 49
  • [36] Fragment-based lead discovery and optimization using the SHAPES strategy
    Lepre, CA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2762 - U2762
  • [37] Lead optimization and biological evaluation of fragment-based cN-II inhibitors
    Guillon, Remi
    Rahimova, Rahila
    Preeti
    Egron, David
    Rouanet, Sonia
    Dumontet, Charles
    Aghajari, Nushin
    Jordheim, Lars Petter
    Chaloin, Laurent
    Peyrottes, Suzanne
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 168 : 28 - 44
  • [38] Identification of potent, selective JAK2 inhibitors using a fragment-based screening approach
    Wallis, N. G.
    Chessari, G.
    Curry, J. E.
    Hamlett, C.
    Lewry, K. A.
    Lyons, J.
    Richardson, C. J.
    Tisi, D.
    Walker, D.
    Woodhead, A. J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 180 - 180
  • [39] Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach
    Jacobsen, Jennifer A.
    Fullagar, Jessica L.
    Miller, Melissa T.
    Cohen, Seth M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (02) : 591 - 602
  • [40] MEDI 243-Discovery of high affinity beta-secretase inhibitors using fragment-based lead generation and structure-based design
    Albert, Jeffrey S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234